Drug provides better kidney transplant survival rates than current standard of care
For the first time, an immunosuppressive agent has shown better organ survival in kidney transplant recipients than a calcineurin inhibitor, the current standard of care, according to a worldwide study led by UC San Francisco ...
Jan 27, 2016
0
25